Drug Type Small molecule drug |
Synonyms HG 3001 |
Target |
Mechanism HDAC1 inhibitors(Histone deacetylase 1 inhibitors), HDAC2 inhibitors(Histone deacetylase 2 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Liver Cancer | Phase 1 | CN | 05 Jan 2020 | |
Lung Cancer | Phase 1 | CN | 22 Dec 2019 | |
Breast Cancer | Phase 1 | CN | 19 Dec 2019 |